Medication info
Tenegliptin Extended-Release Tablets 20/1000 mg

Tenegliptin Extended-Release Tablets 20/1000 mg

Prescription medicationTabletOral
Ingredient · strength
Teneligliptin Hydrochloride Hydrate›26mg / 1 tabletMetformin Hydrochloride›1000mg / 1 tablet
Manufacturer / importer
Mothers Pharmaceutical Co., Ltd.
Appearance
Pink, oval, extended-release film-coated tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 202201237 · Approved 2022.03.29 · Insurance code 622804730

Summary

Main use
Improves glycemic control in patients with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
The dose of this medicine should be determined based on each patient's current treatment regimen, efficacy, and tolerability. This medicine is generally administered once daily with the evening meal, with gradual dose titration to reduce gastrointestinal adverse reactions associated with metformin. Take 1 tablet of this medicine 20/1000mg extended-release tablet once daily. Patients taking this medicine 10/750mg or 10/500mg extended-release tablets should take 2 tablets together once daily. For patients whose blood glucose is not adequately controlled with metformin monotherapy, the initial dose of this medicine should provide teneligliptin 20 mg once daily and the patient's existing dose of metformin. For patients switching to this medicine from combination therapy with teneligliptin and metformin, treatment with this medicine may be initiated at the existing doses of teneligliptin and metformin. When switching from immediate-release to extended-release metformin, blood glucose control should be closely monitored and the dose adjusted appropriately. When coadministered with a sulfonylurea, consider reducing the sulfonylurea dose to reduce the risk of hypoglycemia. The maximum recommended daily dose is teneligliptin 20mg and extended-release metformin 2000mg. The safety and efficacy of this medicine have not been specifically evaluated in patients switching to this medicine from other antihyperglycemic agents. Since changes may lead to changes in blood glucose control, any change in treatment for patients with type 2 diabetes should be made under close monitoring. To maintain the extended-release properties, swallow this medicine whole without splitting, crushing, grinding, or chewing.

Ingredients

Manufacturer
Mothers Pharmaceutical Co., Ltd.

Efficacy & effects

Improves glycemic control in patients with type 2 diabetes mellitus

View approved original text

This medication is used to help control blood glucose levels in patients with type 2 diabetes taking tenegliptin and metformin together. It aids in the effective management of blood glucose by supporting fundamental treatment methods such as diet control and exercise. Therefore, this drug is very suitable for improving blood glucose control.

How to take

Adult dose

The dose of this medicine should be determined based on each patient's current treatment regimen, efficacy, and tolerability. This medicine is generally administered once daily with the evening meal, with gradual dose titration to reduce gastrointestinal adverse reactions associated with metformin. Take 1 tablet of this medicine 20/1000mg extended-release tablet once daily. Patients taking this medicine 10/750mg or 10/500mg extended-release tablets should take 2 tablets together once daily. For patients whose blood glucose is not adequately controlled with metformin monotherapy, the initial dose of this medicine should provide teneligliptin 20 mg once daily and the patient's existing dose of metformin. For patients switching to this medicine from combination therapy with teneligliptin and metformin, treatment with this medicine may be initiated at the existing doses of teneligliptin and metformin. When switching from immediate-release to extended-release metformin, blood glucose control should be closely monitored and the dose adjusted appropriately. When coadministered with a sulfonylurea, consider reducing the sulfonylurea dose to reduce the risk of hypoglycemia. The maximum recommended daily dose is teneligliptin 20mg and extended-release metformin 2000mg. The safety and efficacy of this medicine have not been specifically evaluated in patients switching to this medicine from other antihyperglycemic agents. Since changes may lead to changes in blood glucose control, any change in treatment for patients with type 2 diabetes should be made under close monitoring. To maintain the extended-release properties, swallow this medicine whole without splitting, crushing, grinding, or chewing.

Precautions

This medication helps regulate blood glucose. However, it may very rarely cause a serious condition known as lactic acidosis; if symptoms occur, medical attention should be sought immediately. Additionally, caution is advised as hypoglycemia may occur when used with insulin or other diabetes medications. Patients with moderately decreased kidney function, heart failure, liver dysfunction, or those in acute infection or severe trauma should not take this medication. This drug should be temporarily discontinued before and after tests using contrast agents, and can be resumed once kidney function is confirmed to be normal post-exam. It is safer for pregnant women or those who may become pregnant not to take this medication. During treatment, one should be well aware of hypoglycemic symptoms and consume sugars or consult a doctor immediately if symptoms occur. This medication can affect liver and kidney functions, so regular blood and kidney function tests should be conducted. Excessive alcohol consumption can increase the risk of lactic acidosis; therefore, it is advisable to avoid it. Elderly patients may experience decreased kidney function, requiring dosage adjustments and monitoring of renal function. In cases of surgery or severe illness, medication may need to be temporarily halted; consult with healthcare professionals. This medication may interact with certain drugs, so inform your doctor or pharmacist of any other medications you are currently taking. Finally, safety in children and adolescents has not been established, so use this medication with caution in these populations.

Side effects

  • Severe lactic acidosis
  • hypoglycemia
  • constipation
  • bowel obstruction
  • liver dysfunction
  • interstitial pneumonia
  • dermatitis herpetiformis
  • acute pancreatitis
  • dizziness
  • abdominal distension
Show 103 more
  • abdominal discomfort
  • nausea
  • abdominal pain
  • bloating
  • stomatitis
  • gastric polyps
  • colon polyps
  • duodenal ulcer
  • gastroesophageal reflux disease
  • diarrhea
  • decreased appetite
  • elevated amylase
  • elevated lipase
  • increased AST (GOT)
  • increased ALT (GPT)
  • elevated GGT
  • elevated ALP
  • proteinuria
  • ketonuria
  • potential hematuria
  • eczema
  • rash
  • itching
  • allergic dermatitis
  • arthralgia
  • increased CK (CPK)
  • elevated serum potassium levels
  • malaise
  • allergic rhinitis
  • increased serum uric acid
  • peripheral edema
  • hypoglycemia
  • tremors
  • headache
  • weakness
  • hunger
  • fatigue
  • facial edema
  • dyspepsia
  • nausea
  • viral upper respiratory infection
  • shingles
  • rhinitis
  • cold sweats
  • diabetic retinopathy
  • decreased vision
  • cough
  • pulmonary congestion
  • dyspnea
  • drug overdose
  • benign prostatic hyperplasia
  • headache
  • diarrhea
  • epigastric pain
  • gastritis
  • dizziness
  • shingles
  • limb pain
  • nasopharyngitis
  • bone fracture
  • nausea
  • vomiting
  • chronic gastritis
  • irritable bowel syndrome
  • fatigue
  • cerebral infarction
  • hyperglycemia
  • depression
  • vertigo
  • pressure ulcer
  • urticaria
  • cataract
  • glaucoma
  • blurred vision
  • age-related macular degeneration
  • hyperthyroidism
  • hyperparathyroidism
  • coronary artery disease
  • unstable angina
  • angina pectoris
  • otalgia
  • iron deficiency anemia
  • food allergy
  • hearing loss
  • endolymphatic hydrops
  • increased blood creatinine
  • increased blood urea
  • anemia
  • atrial fibrillation
  • hypothyroidism
  • insomnia
  • ovarian cyst
  • vulvar pruritus
  • menopausal symptoms
  • biliary obstruction
  • toxic hepatitis
  • chronic cholecystitis
  • non-alcoholic fatty liver disease
  • alcoholic liver disease
  • eyelid injury
  • ligament sprain
  • lip injury
  • contusion

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture. The storage temperature should be kept between 1 and 30 degrees Celsius to safely maintain the drug’s effectiveness.

Appearance and packaging

Appearance

Pink, oval, extended-release film-coated tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.